ATI RN
ATI RN Mental Custom Health Next Gen Questions
Extract:
Question 1 of 5
Which statement made by a patient prescribed bupropion (Wellbutrin) demonstrates that the medication education the patient received was effective? Select all that apply.
Correct Answer: A
Rationale: The correct answer is A because it demonstrates the patient understands the dual purpose of bupropion - treating depression and aiding smoking cessation. This indicates comprehension of the medication's intended effects.
Choice B is incorrect as weight loss is a common side effect, not weight gain.
Choice C is incorrect as a history of seizures is a contraindication for bupropion.
Choice D is incorrect as bupropion is not known to cause drowsiness.
Question 2 of 5
Which drug group calls for nursing assessment for development of abnormal movement disorders among individuals who take therapeutic dosages?
Correct Answer: B
Rationale: The correct answer is B: Antipsychotics. Antipsychotics are known to cause abnormal movement disorders like tardive dyskinesia, dystonia, and akathisia. Nursing assessment is crucial to monitor for these side effects. SSRIs (
A), Benzodiazepines (
C), and Tricyclic antidepressants (
D) do not typically cause abnormal movement disorders. Monitoring for these specific side effects is not a priority with these drug groups.
Question 3 of 5
The nurse administers each of the following drugs to various patients. The patient who should be most carefully assessed for fluid and electrolyte imbalance is the one receiving:
Correct Answer: A
Rationale: The correct answer is A: Lithium (Eskalith). Lithium is known to cause nephrogenic diabetes insipidus, leading to excessive urination and potential dehydration.
Therefore, the patient receiving lithium should be carefully assessed for fluid and electrolyte imbalances. Clozapine (
B), Diazepam (
C), and Amitriptyline (
D) do not have a significant impact on fluid and electrolyte balance compared to lithium.
Question 4 of 5
A psychiatric nurse is reviewing prescriptions for a patient with major depression at the county clinic. Since the patient has a mild intellectual disability, the nurse would question which classification of antidepressant drugs:
Correct Answer: B
Rationale: The correct answer is B: Monoamine oxidase inhibitors. Due to the patient's mild intellectual disability, MAOIs would be questioned because they have a higher risk of adverse effects, dietary restrictions, and drug interactions compared to other antidepressants. Selective serotonin reuptake inhibitors (
Choice
A) and serotonin and norepinephrine reuptake inhibitors (
Choice
C) are safer options for patients with intellectual disabilities as they have fewer side effects and interactions.
Choice D is incorrect as all categories of antidepressants may not be suitable for the patient.
Question 5 of 5
The mental health team is determining treatment options for a male patient who is experiencing psychotic symptoms. Which question(s) should the team answer to determine whether a community outpatient or inpatient setting is most appropriate? Select all that apply.
Correct Answer: C
Rationale: The correct answer is C: Does the patient have experiences with either community or inpatient mental healthcare facilities? This question is crucial in determining the most appropriate setting for the patient's treatment. If the patient has prior experience with either setting, it can help the mental health team understand which environment may be more beneficial for the patient's current needs. If the patient has had positive experiences in a community outpatient setting, they may be more likely to benefit from that environment. On the other hand, if the patient has had previous success in an inpatient setting, that may be a more appropriate option. This question helps the team tailor the treatment plan to the patient's individual needs based on their past experiences.
Choices A, B, and D are incorrect as they do not directly address the patient's past experiences with different treatment settings, which is the most relevant factor in determining the appropriate treatment setting for the patient.